FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/10/095969 [Registered on: 13/10/2025] Trial Registered Prospectively
Last Modified On: 11/10/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   COMPARISION OF DEXMEDETOMIDINE AND MAGNESIUM SULPHATE AS ADJUVANTS WITH HYPERBARIC ROPIVACAINE FOR SPINAL ANAESTHESIA IN INFRAUMBILICAL SURGERIES  
Scientific Title of Study   COMPARISION OF DEXMEDETOMIDINE AND MAGNESIUM SULPHATE AS ADJUVANTS WITH HYPERBARIC ROPIVACAINE FOR SPINAL ANAESTHESIA IN INFRAUMBILICAL SURGERIES: A PROSPECTIVE RANDOMIZED DOUBLE- BLIND CLINICAL STUDY  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR DHARMISHTHABEN HASMUKHBHAI VASAVA 
Designation  SECOND YEAR RESIDENT ANAESTHESIOLOGY 
Affiliation  SIR SAYAJI RAO GAEKWAD HOSPITAL 
Address  ANAESTHESIOLOGY DEPARTMENT SIR SAYAJI RAO GAEKWAD HOSPITAL ANANDPURA VADODARA GUJARAT PIN CODE 390001
SIR SAYAJI RAO GAEKWAD HOSPITAL ANANDPURA VADODARA GUJARAT PIN CODE 390001
Vadodara
GUJARAT
390001
India 
Phone  9925580329  
Fax    
Email  vasavanilu64@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR JALPA BALAT 
Designation  ASSISTANT PROFESSOR 
Affiliation  SIR SAYAJI RAO GAEKWAD HOSPITAL  
Address  ANAESTHESIOLOGY DEPARTMENT SIR SAYAJI RAO GAEKWAD HOSPITAL ANANDPURA VADODARA GUJARAT PIN CODE 390001
SIR SAYAJI RAO GAEKWAD HOSPITAL ANANDPURA VADODARA GUJARAT PIN CODE 390001
Vadodara
GUJARAT
390001
India 
Phone  9909967624  
Fax    
Email  jalpadamor53023@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR JALPA BALAT 
Designation  Assistant Professor 
Affiliation  SIR SAYAJI RAO GAEKWAD HOSPITAL  
Address  ANAESTHESIOLOGY DEPARTMENT SIR SAYAJI RAO GAEKWAD HOSPITAL ANANDPURA VADODARA GUJARAT PIN CODE 390001
SIR SAYAJI RAO GAEKWAD HOSPITAL ANANDPURA VADODARA GUJARAT PIN CODE 390001
Vadodara
GUJARAT
390001
India 
Phone  9909967624  
Fax    
Email  jalpadamor53023@gmail.com  
 
Source of Monetary or Material Support  
SSG Hospital and government medical college Vadodara Gujarat India. pincode 390001 
 
Primary Sponsor  
Name  SIR SAYAJI RAO GAEKWAD HOSPITAL  
Address  SIR SAYAJI RAO GAEKWAD HOSPITAL ANANDPURA VADODARA GUJARAT PIN CODE 390001 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR DHARMISHTHABEN HASMUKHBHAI VASAVA  SSG HOSPITAL  SIR SAYAJI RAO GAEKWAD HOSPITAL ANANDPURA VADODARA GUJARAT PIN CODE 390001
Vadodara
GUJARAT 
9925580329

vasavanilu64@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee for Biomedical and Health Research Vadodara  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: 8||Other Procedures,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  INJECTION DEXMEDETOMIDINE 10 MICROGRAM WITH HYPERBARIC ROPIVACAINE 2.5ML  AFTER PREANESTHETIC EVALUATION,PATIENTS MEETING THE INCLUSION CRITERIAWILL BE SELECTED.INTHE OPERATIONTHEATRE NECESSORY DRUGA AND EQUIPMENTA KEPT READY.SPINAL ANAESTHESIA WILL BE GIVEN IN L3-L4 SPACE.PATIENTS WILL BE DIVIDED IN TO TWO INJECTION HYPERBARIC ROPIVACAINE 2.5 ML WITH INJECTION DEXMEDETOMIDINE 10 MICROGRAM WILL BE GIVEN INTRATHECALLY WITHOUTBARBOTAGE,PATIENT IS IMMEDIEATELY PUT IN SUPINE POSITON WITHOUT RAISING EXTREMITIES AND MONITORING OF PARAMETERS WILL BE STARTED IMMEDIETELY.SENSORY AND MOTOR BLOCKADE REQUIREMENT OF INJECTION EPIDRINE WILL BE OBSERVED 
Intervention  INJECTION MAGNESIUM SULPHATE 75MG WITH INJECTION HYPERBARIC ROPIVACAINE 2.5ML  AFTER PREANESTHETIC EVALUATION,PATIENTS MEETING THE INCLUSION CRITERIA WILL BE SELECTED.INTHE OPERATION THEATRE NECESSORY DRUGS AND EQUIPMENTA KEPT READY.SPINAL ANAESTHESIA WILL BE GIVEN IN L3-L4 SPACE.PATIENTS WILL BE DIVIDED IN TO TWO INJECTION HYPERBARIC ROPIVACAINE 2.5 ML WITH INJECTION MAGNESIUM SULPHATE 75MG WILL BE GIVEN INTRATHECALLY WITHOUT BARBOTAGE,PATIENT IS IMMEDIEATELY PUT IN SUPINE POSITON WITHOUT RAISING EXTREMITIES AND MONITORING OF PARAMETERS WILL BE STARTED IMMEDIETELY.SENSORY AND MOTOR BLOCKADE REQUIREMENT OF INJECTION EPHIDRINE WILL BE OBSERVED  
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Age Group – 18 years to 60 years
2. ASA – I/II/III
3. Infraumbilical surgeries
4. Duration of surgery 2 to 2.5 hrs

 
 
ExclusionCriteria 
Details  1.Patients Refusal
2.Patient with history of previous spine surgery
3.Heart block & ventricular dysfunction
4.Patient with spine deformity
5.Patient on anticoagulant therapy
6.Patient with local site infection
7.Patients with allergy to study drugs
8.Severe hypovolemia



 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Onset and duration of sensory and motor blockade

 
Till 24 hrs
 
 
Secondary Outcome  
Outcome  TimePoints 
1 Post operative analgesia if VAS score greater then and equal to 4 or on patient demand as a rescue analgesia
2 Requirement of Rescue analgesia in 24 hours
3 Hemodynamic changes like HR SBP DBP MAP SPO2
4 Complication if any if any bradycardia hypotension nausea vomiting
shivering,respiratory, depression.
 
Intraoperative and postoperative till 24 hours 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   11/11/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Comparision  of  Dexmedetomidine and Magnesium sulfate as adjuvants  with Hyperbaric Ropivacaine for spinal anaesthesia in infraumbilical surgeries : A Prospective Randomized  Double –Blind  clinical study. 
As per the central limit theorem ,a  sample size of at least 30 is often considered a good enough for reliable  statistical inferences about the population. When a sample  is 30 or greater ,the sampling  distribution  of the population distribution  is not  normal. so we will take  30 cases each in control  and intervention  group in our study.

Group RD

Inj. Hyperbaric Ropivacaine (0.75%) 2.5 ml+ Inj Dexmedetomidine 10micrograms

Group RM

Inj. Hyperbaric Ropivacaine (0.75%) 2.5 ml+ Inj Magnesium sulphate 75mg





  

Primary objectives of the study are

 Onset and duration of sensory and motor  blockade

 

Secondary objectives of the study are

 Post operative  analgesia if VAS score greater then and equal to 4 or on patient  demand as a rescue analgesia

       Requirement of Rescue analgesia in 24 hours

       Hemodynamic  changes like HR SBP DBP MAP SPO2

       Complication if any if any bradycardia hypotension nausea vomiting shivering,respiratory depression

As there is limited study available regarding efficacy of hyperbaric ropivacaine with dexmedetomidine and magnesium sulphate as an adjuvant, so we decide to do comparision of hyperbaric ropivacaine with dexmedetomidine and magnesium sulphate in infraumbilical surgeries with primary aims to onset and duration of  sensory and motor blockage and secondary aims to post operative analgesia, requirement of rescue analgesia , hemodynamic stability and complication if any

 
Close